Used as a chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure supports the development of pyrrolopyrimidine-based drug candidates, offering potential in the creation of kinase inhibitors and neuroprotective agents. The sodium salt form enhances solubility, facilitating its use in aqueous reaction systems during drug manufacturing.